Table 3.
Budget impact of optimal choices for cervical cancer prevention in the Philippines
| Options | TARGET POPULATION (5-yearly) | 5 YEARS BUDGET in million Php (USD) | ANNUAL BUDGET in million Php (USD) | |||||
|---|---|---|---|---|---|---|---|---|
| VIA | Vaccination (3-dose) | Pap Smear | VIA | Vaccination (3-dose) | Pap Smear | Total | ||
| 8 % Pap (35–55) | - | - | 941,758 | - | - | 471 (11.13) | 909 (21.48) | 182 (4.30) |
| 8 % VIA (35–55) | 941,758 | - | - | 94 (2.22) | - | - | 471 (11.13) | 94 (2.22) |
| 80 % VIA (35–45) | 5,597,648 | - | - | 560 (13.23) | - | - | 2,799 (66.13) | 560 (13.23) |
| 80 % VIA (35–50) | 7,663,312 | - | - | 766 (18.10) | - | - | 3,832 (90.54) | 766 (18.10) |
| 80 % VIA (35–55) | 9,417,584 | - | - | 942 (22.26) | - | - | 4,709 (111.26) | 942 (22.26) |
| 80 % Vac 11 + 80 % VIA (35–45) | 5,597,648 | 4,059,120 | - | 560 (13.23) | 11,106 (262.40) | - | 13,905 (328.53) | 2,781 (65.71) |
| 80 % Vac 11 + 80 % VIA (35–50) | 7,663,312 | 4,059,120 | - | 766 (18.10) | 11,106 (262.40) | - | 14,937 (352.92) | 2,987 (70.57) |
| 80 % Vac 11 + 80 % VIA (35–55) | 9,417,584 | 4,059,120 | - | 942 (22.26) | 11,106 (262.40) | - | 15,815 (373.66) | 3,163 (74.73) |
| 80 % Vac 11 + 80 % VIA (30–55) | 15,704,480 | 4,059,120 | - | 1570 (37.09) | 11,106 (262.40) | - | 18,958 (447.92) | 3,792 (89.95) |